Digestive Diseases and Sciences

, Volume 51, Issue 3, pp 623–628 | Cite as

Biliary Cystadenomas: Hormone Receptor Expression and Clinical Management

  • Jason A. Daniels
  • James E. Coad
  • William D. Payne
  • Kambiz Kosari
  • Timothy D Sielaff
Pancreatic and Biliary Disorders


Biliary cystadenomas with mesenchymal stroma are neoplasms whose growth may be hormone sensitive. This study profiled the immunohistochemistry of these lesions to clarify the pathophysiology and define clinical management. Twelve patients with biliary cystadenomas were identified. Tissue was tested with a panel of probes including estrogen and progesterone receptors and compared to pancreatic and ovarian cystadenomas. Epithelial ER, PR, CD117, or SMA expression was negative in all three tumors. Epithelial CD10 expression was seen in 60% biliary, 75% pancreatic, and 0% ovarian tumors. Biliary cystadenoma stromal expression was ER+ (70%), PR+ (60%), CD10+ (40%), and c-kit+ (0%). Symptoms were seen in 92% patients. Percutaneous sclerotherapy and incomplete resection were associated with recurrence. Enucleation was the least morbid surgical technique. A role for hormonally mediated growth of biliary cystadenomas occurring through the stroma, rather than the epithelium, is suggested. Management remains complete surgical resection.

Key Words

biliary cystadenoma liver neoplasm estrogen receptor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Litwin D, Taylor B, Greig P, Langer B: Nonparasitic cysts of the liver the case for conservative surgical management. Ann Surg 205:45–48, 1987PubMedGoogle Scholar
  2. 2.
    Brunt E: Benign tumors of the liver. Clin Liver Dis 51–15, 2001Google Scholar
  3. 3.
    Davies W, Chow M, Nagorney D: Extrahepatic biliary cystadenomas and cystadenocarcinomas. Report of seven cases and review of the literature. Ann Surg 222:619–625, 1995PubMedGoogle Scholar
  4. 4.
    Peny M, Noël J, Gelin M, Deprez C, Verhest A: Hepatobiliary cystadenoma with mesenchymal stroma presentation of one case and review of the literature. Acta Gastroenterol Belg 55:364–368, 1992PubMedGoogle Scholar
  5. 5.
    Edmondson H: Tumors of the liver and intrahepatic bile ducts. In Atlas of Tumor Pathology. Washington, DC, Armed Forces Institute of Pathology, 1958Google Scholar
  6. 6.
    Wouters K, Ectors N, Steenbergen WV, Aerts R, Driessen A, Hoe LV, Geboes K: A pancreatic mucinous cystadenoma in a man with mesenchymal stroma expressing oestrogen and progesterone receptors. Virchows Arch 432:187–189, 1998CrossRefPubMedGoogle Scholar
  7. 7.
    Grayson W, Teare J, Myburgh J, Paterson A: Immunohistochemical demonstration of progesterone receptor in hepatobiliary cystadenoma with mesenchymal stroma. Histopathology 29:461–463, 1996CrossRefPubMedGoogle Scholar
  8. 8.
    Pedram-Canihac M, Bail BL, Rivel J, Blanc J, Saric J, Bioulac-Sage P: Cystadénome hépatobiliare à stroma mésenchymateux une tumeur hormonodépendante? À propos de cinq cas avec étude immunohistochimique des récepteurs hormonaux. Ann Pathol 20:14–18, 2000PubMedGoogle Scholar
  9. 9.
    Suyama Y, Horie Y, Suou T, Hirayama C, Ishiguro M, Nishimura O, Koga S: Oral contraceptives and intrahepatic biliary cystadenoma having an increased level of estrogen receptor. Hepato-gastroenterology 35:171–174, 1988PubMedGoogle Scholar
  10. 10.
    Imai K, Maeda M, Fujiwara H, Okamoto N, Kariya M, Emi N, Takakura K, Kanzaki H, Mori T: Human endometrial stromal cells and decidual cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD10 antigen/neutral endopeptidase. Biol Reprod 46:328–334, 1992CrossRefPubMedGoogle Scholar
  11. 11.
    Devaney K, Goodman Z: Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 18:1078–1091, 1994PubMedGoogle Scholar
  12. 12.
    Yantiss R, Spiro I, Compton C, Rosenberg A: Gastrointestinal stromal tumor verses intra–abdominal fibromatosis of the bowel wall. A clinically important differential diagnosis. Am J Surg Pathol 24:947–957, 2000PubMedGoogle Scholar
  13. 13.
    Woods G: Biliary cystadenocarcinoma case report of hepatic malignancy originating in benign cystadenoma. Cancer 47:2936–2940, 1981PubMedGoogle Scholar
  14. 14.
    Wheeler D, Edmondson H: Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer 56:1434–1445, 1985PubMedGoogle Scholar
  15. 15.
    Mortele K, Ros P: Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21:895–910, 2001PubMedGoogle Scholar
  16. 16.
    Shimada M, Takenaka K, Gion T, Fujiwara Y, Taguchi K, Kajiyama K, Shirabe K, Sugimachi K: Treatment strategy for patients with cystic lesions mimicking a liver tumor. Arch Surg 133:643–646, 1998PubMedGoogle Scholar
  17. 17.
    Chu P, Arber D: Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 113:374–382, 2000PubMedGoogle Scholar
  18. 18.
    Zimmerman A: Tumors of the bile duct—pathologic aspects. In Surgery of the Liver and Biliary Tract. LH Blumgart and Y Fong (ed). London, WB Saunders, 2000, pp 953–975Google Scholar
  19. 19.
    Botero A, Strasberg S: Division of the left hemiliver in man—segments, sectors or sections. Liver Transplant Surg 4:226–231, 1998CrossRefGoogle Scholar
  20. 20.
    Gourley WK, Kumar D, Bouton MS, Fish JC, Nealon W: Cystadenoma and cystadenocarcinoma with mesenchymal stroma of the liver immunohistochemical analysis. Arch Pathol Lab Med 116:1047–1050, 1992PubMedGoogle Scholar
  21. 21.
    Terada T, Kitamura Y, Ohta T, Nakanuma Y: Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas. Virchows Arch 430:37–40, 1997CrossRefPubMedGoogle Scholar
  22. 22.
    Scott F, More L, Dhillon A: Hepatobiliary cystadenoma with mesenchymal stroma expression of oestrogen receptors in formalin-fixed tissue. Histopathology 26:555–558, 1995PubMedGoogle Scholar
  23. 23.
    Ishak K, Willis G, Cummins S, Bullock A: Biliary cystadenoma and cystadenocarcinoma report of 14 cases and review of the literature. Cancer 38:322–338, 1977Google Scholar
  24. 24.
    Moorthy KMN, Houghton P: The management of simple hepatic cysts: sclerotherapy or laparoscopic fenestration. Ann R Coll Surg Engl 83:2001Google Scholar
  25. 25.
    Koffron A, Rao S, Ferrario M, Abecassis M: Intrahepatic biliary cystadenoma: Role of cyst fluid analysis and surgical management in the laparoscopic era. Surgery 136:926–936, 2004CrossRefPubMedGoogle Scholar
  26. 26.
    Sato M, Watanabe Y, Tokui K, Nakata Y, Chen Y, Kawachi K: Hepatobiliary cystadenocarcinoma connected to the hepatic duct: a case report and review of the literature. Hepato-gastroenterology 50:1621–1624, 2003PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • Jason A. Daniels
    • 1
  • James E. Coad
    • 2
  • William D. Payne
    • 3
  • Kambiz Kosari
    • 3
  • Timothy D Sielaff
    • 4
    • 5
  1. 1.Department of Laboratory Medicine and PathologyUniversity of Minnesota Medical SchoolMinneapolis
  2. 2.Department of PathologyWest Virginia University School of MedicineMorgantownUSA
  3. 3.Department of SurgeryUniversity of Minnesota Medical SchoolMinneapolis
  4. 4.Department of Virginia Piper Cancer InstituteAbbott Northwestern HospitalMinneapolis
  5. 5.Virginia Piper Cancer InstituteAbbott Northwestern HospitalMinneapolisUSA

Personalised recommendations